Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probuphine in Opioid Dependence
NCT01114308Phase 3Completed
- Sponsor
- Titan Pharmaceuticals, Inc.
- Start
- Apr 2010
- Primary completion
- May 2011
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
A Phase 3 trial of buprenorphine implant in opioid use disorder (OUD), sponsored by Titan Pharmaceuticals, Inc.. Started Apr 2010; status: completed.
02
Drugs
buprenorphine implant
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01114308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01114308.